Bioavailability Enhancement Solutions

Poor bioavailability remains one of the most significant challenges in drug development, particularly for poorly water-soluble compounds where limited absorption can hinder therapeutic performance. Advanced formulation strategies such as amorphous solid dispersions, spray drying, melt extrusion, and lipid-based delivery systems are helping developers improve drug exposure while reducing development risk.

From physicochemical characterization and solubility screening through formulation optimization, analytical testing, and GMP manufacturing, an integrated approach can streamline the journey from concept to clinic. Flexible batch sizes, high-potency handling capabilities, and robust analytical support further enable efficient scale-up and knowledge transfer across development stages. By combining specialized expertise, proven technologies, and science-driven collaboration, development teams can better address solubility limitations, accelerate timelines, and create formulations designed to maximize clinical potential.

Learn how innovative bioavailability enhancement strategies can help overcome formulation barriers and support the successful advancement of challenging drug candidates.